Use Of The ABSS In Infants With ARIS Treated With Outpatient Respiratory Physiotherapy
Launched by FISIORESPIRACIÓN · Jul 25, 2019
Trial Information
Current as of August 02, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Under 24 months
- • ARIS diagnosed
- • Medical indication of respiratory physiotherapy
- • Evaluated during the first outpatient respiratory physiotherapy treatment
- Exclusion Criteria:
- • Chronic desease
- • ABSS ≥ 7
- • Temperature≥ 38ºC
- • Stridor
- • Expiratory groan
- • Sternal sinking
- • Any sign or symptom indicative of need for urgent medical evaluation
About Fisiorespiración
Fisiorespiración is a clinical trial sponsor dedicated to advancing respiratory health through innovative research and development. With a strong focus on evidence-based therapies, the organization collaborates with healthcare professionals and research institutions to conduct rigorous clinical trials aimed at improving patient outcomes in respiratory conditions. Fisiorespiración is committed to adhering to the highest ethical standards and regulatory requirements, ensuring the safety and well-being of participants while contributing to the scientific community's understanding of respiratory diseases. Through its comprehensive approach, Fisiorespiración strives to deliver transformative solutions that enhance quality of life for individuals affected by respiratory issues.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madrid, , Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials